Akido, a US healthcare provider, has announced plans to build what it describes as the country’s first AI-native health system, expanding its proprietary ScopeAI technology across 100 clinics, virtual care and field medicine services.
The initiative will provide ScopeAI-enabled care to a population of approximately 1 million patients across California, New York City and Rhode Island. The company said the technology is designed to organise patients’ clinical information in real time, providing physicians with a diagnostic head start and reducing administrative and cognitive workloads during consultations.
ScopeAI listens during clinical visits and organises relevant information to help physicians build a comprehensive clinical picture. Akido said the technology is intended to allow doctors to spend more time focused on patients and clinical decision-making rather than administrative tasks.
The move comes amid growing concerns over physician shortages in the US. The Association of American Medical Colleges (AAMC) has projected that the country could face a shortage of up to 86,000 physicians by 2036, increasing pressure on healthcare systems to improve clinical efficiency and support medical professionals.
“Doctors are leaving medicine because the system asks them to do more with less every year. ScopeAI removes the administrative weight of the visit and supports investigative intake, so physicians can spend their time on what only a human doctor can do,” said Prashant Samant, CEO and Co-Founder, Akido.
Akido is also deploying ScopeAI in its street medicine programme, which provides continuous healthcare to people experiencing homelessness in Los Angeles. The technology is being used on iPads in field settings, where clinicians may have limited access to patient records and must develop a patient’s clinical history in real time.
According to Akido, ScopeAI helps clinicians identify relevant issues and maintain consistency in clinical intake, potentially supporting care delivery in challenging environments.
“With a patient who has no chart and no fixed address, you're building the whole picture from scratch, in real time, often in an encampment with no privacy and no time to spare. ScopeAI gets me to the real issue fast. It knows what to ask, it's comprehensive, and it performs the same way every single time,” said Dr Jocelyn Dee, MD, Street Medicine Physician, Akido.
Alongside the expansion of ScopeAI, Akido has introduced new technical leadership and launched an AI Clinical Advisory Council to support the development of its AI-enabled healthcare model. The company has also retired “Labs” from its name and introduced Akido Medical as the brand for its AI-native clinics.
